To the Editor: The editorial by Coiera and Westbrook raises some important points.1 Appropriate models of governance (vis-à-vis regulation) surrounding clinical software are required if we are to drive innovative technology on a course that is safe and effective for patients.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC.
Correspondence: karenleefox@optusnet.com.au
- 1. Coiera EW, Westbrook JI. Should clinical software be regulated? [editorial]. Med J Aust 2006; 184: 600-601. <MJA full text>
- 2. Sauer C. Why information systems fail: a case study approach. Oxfordshire: Alfred Waller Ltd, 1993.
- 3. Bomba D, Land T. The feasibility of implementing an electronic prescribing decision support system: a case study of an Australian public hospital. Aust Health Rev 2006; 30: 380-388.
- 4. Beilby JJ, Duszynski AJ, Wilson A, Turnbull DA. Electronic decision support systems at point of care: trusting the deus ex machine [editorial]. Med J Aust 2005; 183: 99-100. <MJA full text>
- 5. Evans SM, Cameron PA, Myles P, et al. Measurement, monitoring and clinical governance [letter]. Med J Aust 2005; 183: 543. <MJA full text>
Online responses are no longer available. Please refer to our instructions for authors page for more information.